2015
DOI: 10.1016/j.bios.2015.03.048
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatic electrochemical detection of epidemic-causing Vibrio cholerae with a disposable oligonucleotide-modified screen-printed bisensor coupled to a dry-reagent-based nucleic acid amplification assay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 23 publications
0
12
0
Order By: Relevance
“…Recently, Yu et al (2015) developed a nucleic acidsensing platform for detection of toxigenic Vibrio cholerae serogroups O1 and O139. The sensitivity and specificity (100%) of the platform showed excellent diagnostic capabilities when tested with 168 spiked stool samples.…”
Section: Molecular-based Methodsmentioning
confidence: 99%
“…Recently, Yu et al (2015) developed a nucleic acidsensing platform for detection of toxigenic Vibrio cholerae serogroups O1 and O139. The sensitivity and specificity (100%) of the platform showed excellent diagnostic capabilities when tested with 168 spiked stool samples.…”
Section: Molecular-based Methodsmentioning
confidence: 99%
“…This datum is collected in real time due to the magnitude and phase changing from the input to the output signal at the frequency range. To properly provide a solution for the WHO concept for new developing biosensors and answer the criteria of ASSURED [7], electrochemical DNA biosensors must be affordable. The electrochemical EIS system is a point-of-care, label free, low cost, highly sensitive method of biosensor detection [1,16].…”
Section: Resultsmentioning
confidence: 99%
“…The most common method used clinically is culture isolation of the genes to determine the microbial identification and epidemiology [3]. However, currently culture based nucleic acid detection is a lengthy process with a further lengthened period upon which treatment is administered [7]. Due to these technical limitations the World Health Organization has attempted to address this problem.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The optimised dry-reagent LATE-PCR mix (20 μl) contained PCR buffer, 320 μM dNTP mix, 2.5 mM MgCl 2 , 0.5 μM ctxA_RX, 0.1 μM ctxA_FL, 0.5 μM IAC_FX, 0.05 μM IAC_RL, 5% (w/v) raffinose, 6.25% (w/v) Ficoll, 0.25 mg/ml BSA, 0.01% (w/v) orange G, 1.5 U deglycerolised Taq DNA polymerase, 10 pg of internal amplification control (IAC) template and ultrapure water. The aqueous LATE-PCR mix was lyophilised using Heto Lyolab 3000 as described by Yu et al (2015) until an amorphous glassy matrix was formed. The thermostabilised LATE-PCR mixes were stored in a desiccator or sealed in aluminium pouches containing silica gel.…”
Section: Preparation Of Thermostabilised Late-pcr MIXmentioning
confidence: 99%